Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 50

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma

Riggle, Kevin M., Riehle, Kimberly J., Kenerson, Heidi L., Turnham, Rigney, Homma, Miwako K., Kazami, Machiko, Samelson, Bret, Bauer, Renay, McKnight, G. Stanley, Scott, John D., Yeung, Raymond S. · 2016 · Pediatric Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/pr.2016.36

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 37

  1. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010;42 Suppl 3:S206–14. · DOI · Paper page
  2. Hoshida Y. Molecular signatures and prognosis of hepatocellular carcinoma. Minerva Gastroenterol Dietol 2011;57:311–22.
  3. Kan Z, Zheng H, Liu X, et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res 2013;23:1422–33. · DOI · Paper page
  4. Qi LN, Li LQ, Chen YY, et al. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China. PLoS One 2013;8:e83465. · doi:10.1371/journal.pone.0083465
  5. Mayo SC, Mavros MN, Nathan H, et al. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective. J Am Coll Surg 2014;218:196–205. · DOI
  6. Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica (Cairo) 2012;2012:743790.
  7. Honeyman JN, Simon EP, Robine N, et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 2014;343:1010–4. · DOI · Paper page
  8. Xu L, Hazard FK, Zmoos AF, et al. Genomic analysis of fibrolamellar hepatocellular carcinoma. Hum Mol Genet 2015;24:50–63. · DOI · Paper page
  9. Cheung J, Ginter C, Cassidy M, et al. Structural insights into mis-regulation of protein kinase A in human tumors. Proc Natl Acad Sci USA 2015;112:1374–9. · DOI · Paper page
  10. Amieux PS, McKnight GS. The essential role of RI alpha in the maintenance of regulated PKA activity. Ann N Y Acad Sci 2002;968:75–95. · DOI · Paper page
  11. Uhler MD, McKnight GS. Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem 1987;262:15202–7. · DOI · Paper page
  12. Dell’Acqua ML, Scott JD. Protein kinase A anchoring. J Biol Chem 1997;272:12881–4. · DOI · Paper page
  13. Scott JD, Pawson T. Cell signaling in space and time: where proteins come together and when they’re apart. Science 2009;326:1220–4. · DOI · Paper page
  14. Pritchard CC, Salipante SJ, Koehler K, et al. Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. J Mol Diagn 2014;16:56–67. · DOI · Paper page
  15. Newlon MG, Roy M, Hausken ZE, Scott JD, Jennings PA. The A-kinase anchoring domain of type IIalpha cAMP-dependent protein kinase is highly helical. J Biol Chem 1997;272:23637–44. · DOI
  16. Wu J, Brown SH, von Daake S, Taylor SS. PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity. Science 2007;318:274–9. · DOI · Paper page
  17. Zick SK, Taylor SS. Interchain disulfide bonding in the regulatory subunit of cAMP-dependent protein kinase I. J Biol Chem 1982;257:2287–93. · DOI
  18. Scott JD, Stofko RE, McDonald JR, Comer JD, Vitalis EA, Mangili JA. Type II regulatory subunit dimerization determines the subcellular localization of the cAMP-dependent protein kinase. J Biol Chem 1990;265:21561–6. · DOI · Paper page
  19. Carnegie GK, Means CK, Scott JD. A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 2009;61:394–406. · DOI · Paper page
  20. Smith FD, Reichow SL, Esseltine JL, et al. Intrinsic disorder within an AKAP-protein kinase A complex guides local substrate phosphorylation. Elife 2013;2:e01319. · DOI
  21. Scott JD, Fischer EH, Demaille JG, Krebs EG. Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1985;82:4379–83. · DOI · Paper page
  22. Scott JD, Glaccum MB, Fischer EH, Krebs EG. Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1986;83:1613–6. · DOI · Paper page
  23. Welch EJ, Jones BW, Scott JD. Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 2010;10:86–97. · DOI · Paper page
  24. Beuschlein F, Fassnacht M, Assié G, et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N Engl J Med 2014;370:1019–28. · DOI · Paper page
  25. Carnegie GK, Scott JD. A-kinase anchoring proteins and neuronal signaling mechanisms. Genes Dev 2003;17:1557–68. · DOI
  26. Lania AG, Mantovani G, Ferrero S, et al. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res 2004;64:9193–8. · DOI
  27. Mantovani G, Bondioni S, Ferrero S, et al. Effect of cyclic adenosine 3’,5’-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2005;90:6721–4. · DOI
  28. Riehle KJ, Yeh MM, Yu JJ, et al. mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma. Mod Pathol 2015;28:103–10. · DOI
  29. Pringle DR, Vasko VV, Yu L, et al. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice. J Clin Endocrinol Metab 2014;99:E804–12. · DOI
  30. Canton DA, Keene CD, Swinney K, et al. Gravin is a transitory effector of polo-like kinase 1 during cell division. Mol Cell 2012;48:547–59. · DOI
  31. Carnegie GK, Soughayer J, Smith FD, et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell 2008;32:169–79. · DOI
  32. Langeberg LK, Scott JD. Signalling scaffolds and local organization of cellular behaviour. Nat Rev Mol Cell Biol 2015;16:232–44. · DOI · Paper page
  33. Smith FD, Langeberg LK, Cellurale C, et al. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat Cell Biol 2010;12:1242–9. · DOI
  34. Sunahara RK, Dessauer CW, Whisnant RE, Kleuss C, Gilman AG. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem 1997;272:22265–71. · DOI · Paper page
  35. Collier NA, Weinbren K, Bloom SR, Lee YC, Hodgson HJ, Blumgart LH. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1984;1:538–40. · doi:10.1016/s0140-6736(84)90934-6
  36. Dan YY, Riehle KJ, Lazaro C, et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci USA 2006;103:9912–7. · DOI · Paper page
  37. Voet D, Voet JG. Biochemistry. 3rd edn. New York, NY: Wiley, 2004:480.

Cited by

Metadata

Authors
Riggle, K. M., Riehle, K. J., Kenerson, H. L., Turnham, R., Homma, M. K., Kazami, M., Samelson, B., Bauer, R., McKnight, G. S., Scott, J. D., & Yeung, R. S.
Venue
Pediatric Research
Published
2016-03-08
Volume
80
Issue
1
Pages
110-118
ISSN
  • 0031-3998
  • 1530-0447
Cited by
50
References
1
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.